Trials / Unknown
UnknownNCT05067920
Correlation Between Cycle Threshold (Ct) Values in COVID-19, Health Status and Laboratory Biomarkers in the Population of Medellin- Colombia Evaluated in a Specialized Laboratory.
Correlation Between Cycle Threshold (Ct) Values in RT-PCR - SARS-CoV-2, Health Status and Laboratory Biomarkers in the Population of Medellin- Colombia Evaluated in a Specialized Laboratory
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Universidad de Antioquia · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the correlation between the symptomaticity, Ct value, laboratory biomarkers associated to COVID-19 and the disease progression in hospitalized patients and outpatients with SARS-CoV2 infection diagnosed by RT-PCR assay for nasopharyngeal swab specimens in a specialized laboratory at Medellin,Colombia.
Detailed description
After being informed about the study, all patients giving written informed consent will undergo a serial of test related to COVID-19. Rh and blood type will be obtained using the Colombian ID card or official document. All symptomatic and asymptomatic COVID19-positive patients will be evaluated for a period of 4 weeks at three different times of the study. In a single time, the mitochondrial DNA will be measured, and the variability in the CT value, hemogram, cytokine levels, ratio of CD4 + / CD8 + lymphocytes, levels of dehydrogenase lactate, ferritin and D-dimer, antibodies IgG and IgM, will be measured on day 5, day 14 and day 28. In addition, spike S protein sequencing and growing the virus in cell culture that meet specific criteria will be performed. A physician will do clinical follow up through the period of the study for each patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Levels of SARS-COV-2 antibodies | Study of the SARS-COV-2 antibodies of COVID-19 IgM ( day 5th and 14th) and IgG ( day 14th and 28th) |
| DIAGNOSTIC_TEST | rRT-PCR SARS-Cov-2 | Real time RT-PCR for COVID-19 diagnosis at day 5th,14th and 28th |
| DIAGNOSTIC_TEST | Hematological and immunological biomarkers | Laboratory data measure at day 5th,14th and 28th: Hemogram, cytokine levels, ratio of CD4 + / CD8 + lymphocytes, and levels of dehydrogenase lactate, ferritin, D-dimer. |
| DIAGNOSTIC_TEST | Mitochondrial DNA | One time quantification mitochondrial DNA haplogroup. |
| DIAGNOSTIC_TEST | SARS-CoV-2 Viral Culturing | Probability of isolating SARS-Cov-2 in cell culture related to CT value above 32. |
| DIAGNOSTIC_TEST | Sequencing COVID-19 | Sequencing viral protein spike (S) COVID-19 related to CT value below 15. |
Timeline
- Start date
- 2021-09-27
- Primary completion
- 2022-01-30
- Completion
- 2022-01-31
- First posted
- 2021-10-05
- Last updated
- 2021-12-28
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT05067920. Inclusion in this directory is not an endorsement.